ALZN (Alzamend) EV/EBITDA Multiple
The EV/EBITDA price chart for Alzamend Neuro, Inc. (ALZN) shows a metric of 0.00. The business focuses on combating dementia by developing the AL001 lithium platform and the new AL002 vaccine. Alzamend Neuro, Inc. (ALZN) is implementing ESG principles, ensuring biosafety and the ethics of medical testing. However, its future relies on early-stage trial results and the ability to attract investment in the absence of stable profits.
alzamend.com - analytical breakdowns and key metrics (ALZN)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
ALZN - Company Net Income|Future Profit Alzamend Neuro, Inc.|ALZN - P/E Multiple|Future Price to Earnings Alzamend Neuro|ALZN - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alzamend Neuro|ALZN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Alzamend Neuro|ALZN - Earnings per share for the trailing year|Quarterly EPS earnings growth alzamend.com|ALZN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Alzamend Neuro, Inc.
- sales and revenue data:
Fundamental company valuation:Alzamend (ALZN)
For the biotech firm Alzamend Neuro, Inc. (ALZN), which burns capital during early-stage research, a classic EV/EBITDA valuation becomes an indicator of the gap between business value and the absence of operating profit. This ratio compares the total value of the asset with its ability to generate income before taxes and depreciation, highlighting the debt load. By analyzing the trend level of the company's EV/EBITDA, an investor sees a speculative model where value is supported by expectations rather than actual cash flow.
Key competitors
Biogen Corp - Enterprise Value to EBITDA Ratio|NBIX (Neurocrine Corp) - Company Value to Operating Income Before Depreciation Ratio|Regencell Bioscience - EV/EBITDA Multiple|AXSM - EV/EBITDA Multiple|ACADIA Pharmaceuticals Inc. (ACAD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Xenon Pharmaceuticals Inc.|VKTX (Viking Pharma) - EV/EBITDA Multiple|Company Value to EBITDA Supernus Corp SUPN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Catalyst Pharmaceuticals (CPRX)|denalitherapeutics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple HRMY (Harmony Biosciences Holdings, Inc.)|BHVN: Enterprise Value to Operating Income Before Depreciation|AMLX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TRVI (Trevi Corp)|Praxis Precision Medicines (PRAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation AVXL|CBLL (CeriBell) - EV/EBITDA Multiple|Company Value to EBITDA Prothena Corporation PLC PRTA|Enterprise Value to EBITDA Ratio ALEC (Alector, Inc.)|EV/EBITDA Multiple Annexon Biosciences Inc. (ANNX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Omeros OMER|Business Value to Operating Income Before Depreciation NGNE|ACIU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Voyager Therapeutics Inc|NMRA (Neumora Therapeutics Inc) - Enterprise Value to EBITDA Ratio|Scilex Holding Company, Inc. - Business Value to Operating Income Before Depreciation|TVGN (Tevogen Bio Holdings) - EV/EBITDA Multiple|Alpha Cognition Corp (ACOG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple SAVA (Cassava)|ASRT - Enterprise Value to EBITDA Ratio|COYA: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Vistagen Therapeutics VTGN|OVID: EV/EBITDA Multiple|Acumen Pharmaceuticals Inc. (ABOS) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CervoMed Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ATHE|Enterprise Value to EBITDA Ratio CLNN (Clene Inc.)|PEPG: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Jupiter Neurosciences JUNS|RLMD: Enterprise Value to Operating Income Before Depreciation|ANVS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRCE (Grace Therapeutics, Inc.) - Enterprise Value to Operating Income Before Depreciation|AIFF: EV/EBITDA Multiple|Company Value to EBITDA Klotho Neurosciences (KLTO)|Enterprise Value to EBITDA Ratio NRSN|EV/EBITDA Multiple Reviva Pharmaceuticals Holdings Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Company Value to EBITDA|Neuphoria - EV/EBITDA Multiple|NERV - EV/EBITDA Multiple|Athira (ATHA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADXN (Addex) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio CYCN|Protagenic - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple KTTA|EV/EBITDA Multiple cortigent.com (CRGT)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avenue Therapeutics, Inc ATXI|BCLI - Enterprise Value to EBITDA Ratio|Cara Therapeutics, Inc. - EV/EBITDA Multiple|Company Value to EBITDA chromocell.com|eliemtx.com (ELYM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ITCI|LBPH (Longboard Pharma) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation MRNS (Marinus Pharma)|Enterprise Value to EBITDA Ratio NKGN (NKGen Biotech, Inc.)|NRBO (neurobopharma.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sage Therapeutics SAGE|SNPX: Enterprise Value to Operating Income Before Depreciation|Trevena, Inc - EV/EBITDA Multiple|Company Value to EBITDA Vigil Neuroscience|WENA (Anew Medical, Inc.) - Enterprise Value to EBITDA Ratio|cerevel.com (CERE) - EV/EBITDA Multiple
